EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 110 filers reported holding EPIZYME INC in Q1 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $203,000 | -45.7% | 24,448 | -43.0% | 0.02% | -50.0% |
| Q1 2021 | $374,000 | -35.1% | 42,895 | -11.1% | 0.03% | -8.1% |
| Q3 2020 | $576,000 | +78.9% | 48,260 | +54.7% | 0.04% | +32.1% |
| Q3 2019 | $322,000 | -1.8% | 31,190 | +28.7% | 0.03% | +21.7% |
| Q2 2018 | $328,000 | +52.6% | 24,228 | +41.3% | 0.02% | -4.2% |
| Q4 2017 | $215,000 | -60.6% | 17,151 | -40.0% | 0.02% | -82.5% |
| Q3 2017 | $545,000 | +196.2% | 28,593 | +134.3% | 0.14% | +174.0% |
| Q2 2017 | $184,000 | -52.5% | 12,206 | -67.7% | 0.05% | -2.0% |
| Q2 2016 | $387,000 | -31.4% | 37,801 | +7.3% | 0.05% | +2.0% |
| Q4 2015 | $564,000 | +99.3% | 35,219 | +198.5% | 0.05% | +56.2% |
| Q2 2015 | $283,000 | -73.6% | 11,800 | -79.3% | 0.03% | -70.6% |
| Q1 2015 | $1,072,000 | +22.0% | 57,124 | +22.5% | 0.11% | -29.7% |
| Q4 2014 | $879,000 | – | 46,613 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |